bpc-157 subcutaneous or intramuscular This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make bpc-157 subcutaneous vs intramuscular does

No, this is highly discouraged

Sabat J, Oda K, Ros E

Patients typically experience results for a year, though some find they want a boost around the 6 month mark, especially for those who had more severe symptoms before treatment

However, by this point, you will be deficient in the money you have spent on needless injections, so Save Face recommend a full check-up with either your NHS GP or a private doctor, who can confirm your symptoms and any genuine deficiency with a blood test, and more importantly can prescribe the best type of B12 product and treatment programme to suit your needs.

Iron anaemia Please see the Case study on Ellen for more information

SwitzerlandResearch links Cartalax to local cartilage processes rather than broad inflammatory signaling, which separates its role from peptides studied for wider inflammation effects